Skip to main content
IMVT logo

IMVT · Immunovant, Inc. · Held by Funds

Track IMVT — free
$31.77 -0.75 (-2.31%) At close · Nov 20 Play latest call Q3 2026 earnings call transcript
Market Cap
$6.57B
Shares
206.95M
Volume · Nov 20 704.94K Avg daily vol (3M) 1.41M

Registered funds — mutual funds, ETFs and closed-end funds — whose latest Form N-PORT portfolio report holds this exact listed security, matched by CUSIP. Each row is one fund position with its size, value and weight in that fund.

Fund Ownership of IMVT by Fund Type

Registered funds' Form N-PORT reports for the quarter ended Jun 30, 2026

Index funds and index ETFs hold 8.41% of shares outstanding.

Fund type Of shares outstanding Shares
Index funds 1.42% 2,938,189
Index ETFs 6.99% 14,457,228
Active ETFs 0.07% 140,312
Active funds 7.69% 15,906,720
Unclassified 0.00% 1,544
All registered funds 16.16% 33,443,993
How fund types are measured

Each fund series counts once, with its latest Form N-PORT report dated inside the quarter; only long share positions count, restated to today's split basis. The fund type is the series' latest Form N-CEN answer on or before the quarter end (the index-fund box and the exchange-traded flag), never its name. Unclassified funds have no usable N-CEN; unit investment trusts are among them, so index ownership is a floor. Funds sit inside their advisers' 13F reports, so these shares overlap the 13F figures and are never added to them.

Funds holding IMVT

229 fund positions
Fund Balance Value % of Fund Open
Showing 1–50 of 229 positions
Key facts CIK 1764013 CUSIP 45258J102 13F (30d) 239 filings 222 filers Visit website Investor relations